Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Thomas P. Gallagher, the Chairman and CEO of Miami International Holdings, Inc. (NASDAQ: MIAX), recently completed a series of stock transactions involving the company's common equity. On May 5, 2026, Mr. Gallagher sold 15,771 shares of common stock, totaling approximately $755,746. These sales occurred at varying price points between $47.13 and $4…
National Bank Holdings Corporation announced that its Board of Directors declared a quarterly cash dividend of $0.32 per share payable on June 15, 2026, to shareholders of record as of May 29, 2026. The company operates a community bank franchise with over 100 banking centers across several U.S. states.
Monster Beverage Corporation posted robust financial results for Q1 2026 with net sales increasing 26.9% to $2.35 billion and net income rising 28.6% to $569.5 million. The growth was driven by strong demand in its energy drinks segment, with significant expansion in international markets where sales increased 44.9%. Operating income grew 28.1%, re…
Applied Optoelectronics, Inc. announced Q1 2026 financial results showing record revenue of $151.1 million, driven by broad demand in datacenter and CATV sectors. The company completed first volume shipments of 800G products and forecasts sequential revenue growth and strong volume ramp in H2 2026 as new capacity comes online. Despite a GAAP net lo…
Omada Health has joined Eli Lilly's Employer Connect program to provide its GLP-1 Care Track services directly to employers, enhancing accessibility to obesity medications like Zepbound with coordinated lifestyle support. This partnership adds a new distribution channel alongside existing pharmacy benefit and cash-pay options, addressing employer c…
Milestone Scientific Inc. (NYSE: MLSS), a developer of computerized drug delivery technologies, has scheduled a conference call on May 14, 2026, to announce its financial results for the first quarter ended March 31, 2026. The company will discuss its financial performance, corporate progress, and other developments. The press release also outlines…
StoneX Group Inc.'s subsidiary, The Benchmark Company, is hosting its 4th Annual Consumer One-on-One Conference at the New York Athletic Club on May 19, 2026. The event will connect institutional investors with leading public and private consumer companies to foster dialogue and investment opportunities. Key speakers include StoneX executives and s…
Edward G. Canup, the Chief Banking Officer at Colony Bankcorp Inc (NASDAQ: CBAN), has expanded his personal stake in the company through a recent open-market purchase of common stock. This transaction occurred on May 5, 2026, as documented in a Form 4 regulatory filing. The acquisition comes at a time when the financial institution is managing the …
Clark Joseph Gates, a Senior Vice President and the President of Optimized LED at Penguin Solutions, Inc. (NASDAQ:PENG), has completed a sale of company stock valued at $173,750. The transaction occurred on May 5, 2026, as documented in a recent Form 4 filing submitted to the Securities and Exchange Commission. This divestment takes place against a…
Rocket Lab Corporation, in partnership with Raytheon, has been selected to demonstrate advanced capabilities for the U.S. Space Force's Space Based Interceptor program, aiming to enhance national missile defense, including countering hypersonic threats. This marks a significant expansion of Rocket Lab's role in national security and defense program…
Reliance Global Group, Inc. reported its Q1 2026 financial results and highlighted progress in its Scale51 strategy focused on controlled investments in high-growth technology and life sciences businesses. The company strengthened its balance sheet, improved its net loss compared to the prior year, and expanded ownership in cybersecurity platform E…
Howard Hughes Holdings Inc. reported Q1 2026 financial results demonstrating a 33% increase in Master Planned Communities (MPC) earnings before taxes, driven by higher residential land sales primarily in Bridgeland, alongside steady growth in operating assets net operating income (NOI). Despite a slight decline in net income attributable to common …
Rocket Lab announced it has signed its largest launch deal to date with a confidential customer for multiple launches of its Neutron and Electron rockets, raising its total launch backlog beyond 70 missions valued at more than $2.2 billion. This multi-launch agreement expands Rocket Lab's commercial and government space launch services, demonstrati…
Jeffrey Zerillo, the Senior Vice President of Operations at Prestige Consumer Healthcare Inc. (NASDAQ:PBH), has executed multiple transactions involving the company's common stock. According to recent SEC filings, these disposals occurred on May 5, 2026. The sales come at a time when the consumer healthcare company is undergoing significant structu…
Gilead Sciences reported first-quarter results that beat expectations on both earnings and revenue, and boosted its 2026 sales projection, led by stronger-than-expected demand for its HIV prevention drug Yeztugo. However, the company revised its full-year profit outlook to an adjusted loss because of acquisition-related charges and financing costs …
Crinetics Pharmaceuticals reported robust first quarter 2026 financial results highlighted by $10.3 million in net product revenue from the commercial launch of PALSONIFY, a treatment for acromegaly. The company has expanded its prescriber base and patient enrollment forms, gained significant reimbursement coverage, and achieved regulatory approval…
Nutanix, a leader in hybrid multicloud computing, has announced that it will report its financial results for the third quarter of fiscal 2026 on May 27, 2026, after U.S. markets close. The company will host a conference call and webcast to discuss its results on the same day.
ICU Medical, Inc. announced its first quarter 2026 financial results, showing GAAP revenue decline of 12% year-over-year primarily due to the strategic divestiture of the IV Solutions business. However, non-GAAP organic revenue increased by 1%, and profitability improved significantly with a GAAP net income of $30.1 million compared to a net loss i…
Profound Medical Corp. reported a strong first quarter for 2026, showcasing 104% revenue growth year-over-year, improved operating performance, and reduced net loss. Key achievements include expansion of installed TULSA-PRO systems, positive clinical trial results affirming safety superiority, and Humana becoming the first major US insurer to cover…
Organogenesis Holdings Inc. reported a challenging first quarter of 2026 with net revenue declining 58% year-over-year to $36.3 million, driven by a 63% decrease in Advanced Wound Care sales. The company posted a net loss of $53.2 million, significantly larger than the $18.8 million loss a year earlier. Operating expenses remained high at $106.1 mi…
Fidus Investment Corporation announced its Q1 2026 financial results highlighted by a 35.2% increase in net investment income to $24.6 million ($0.65 per share), a 30.2% rise in total investment income, and increased fee and interest income. The company declared a total dividend of $0.62 per share for Q2 2026, including a supplemental dividend of $…
ImmuCell Corporation, a Nasdaq-listed animal health biologics company specializing in calf health products, announced it will report its unaudited financial results for the quarter ended March 31, 2026, on May 14 after market close. The company plans a conference call on May 15 to discuss the results and expects no changes to previously announced p…
Myriad Genetics announced that its management will participate in the BofA Securities 2026 Health Care Conference and Goldman Sachs 47th Annual Global Healthcare Conference. These events provide platforms for investor engagement and sharing strategic insights about the company's molecular diagnostic testing and precision medicine initiatives.
NextCure announced a business update and financial results for Q1 2026, highlighting the FDA's Fast Track designation for its SIM0505 antibody-drug conjugate targeting platinum-resistant ovarian cancer. The company plans to present Phase 1 data at ASCO 2026 and expand clinical trial sites in North America and Europe. Financially, NextCure reported …
GSI Technology, Inc. announced its financial results for the fourth quarter and fiscal year ended March 31, 2026, highlighting a 22% revenue increase driven by higher SRAM sales and expanded gross margins. The company completed software milestones supporting the upcoming demonstration of its Gemini-II powered drone and secured $2 million in new U.S…
